SHL Medical

Startseite
Schweiz
Zug, Zug
SHL Medical

Wegbeschreibung Website Service kontaktieren

SHL Medical is a pioneering leader in advanced self-injection solutions such as autoinjectors and pen injectors.

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Headquartered in Switzerland with sites across three continents, we offer end-to-end services, from design and development to final assembly, labeling, and packaging, partnering with pharma companies to deliver self-injection systems that enable patients’ independence. View SHL Medical trademarks: https://www.shl-medical.com/trademarks

03/11/2026

Large-volume delivery is not defined by one feature. It is how the choices around the dose work together.

From the molecule and flow path to device format, patient use, and the path ahead, see how those considerations come together in Magnitude.

See Magnitude in action.

02/11/2026

As therapy requirements become more complex, device strategy has to account for more variables earlier in development.

Across PODD®, we explored that shift by sharing how platform design, primary packaging, and human factors can inform more robust delivery strategies.

Thank you to everyone who joined our sessions and exchanged perspectives with our team. We look forward to continuing the conversation about evolving combination product program needs at future events.

30/10/2026

Magnitude continues to drive conversations around large-volume delivery at PODD®.

Alongside discussions around Magnitude’s capability for liquid-liquid formulations, our team also contributed perspectives on high-viscosity drug delivery and the human factors considerations emerging as self-injection expands to longer durations and more complex therapy requirements.

Continue the conversation at Booth #112–113 tomorrow. Hear more from SHL Medical on evolving large-volume delivery research and IV-to-SC transitions through our podium presentation and panel discussion.

29/10/2026

As injection times extend, maintaining clear feedback throughout delivery becomes increasingly important to help users monitor injection progress.

At PODD®, SHL Medical’s Nenad Suknovic, Senior Usability Engineer Research Lead, and Amy King, Head of Insights and Strategy at Cambridge Design Partnership, will share findings from collaborative research evaluating audible feedback for simulated injections lasting up to 60 seconds, exploring the human factors challenges of longer injection durations and their implications for user interface design in large-volume autoinjectors.

Hear the findings today at 3:15 PM and see how audible feedback can shape the user experience for longer injections.

28/10/2026

Standardizing liquid-liquid delivery starts with aligning the container and device from the outset.

At PODD®, a joint tech talk from SHL Medical and Stevanato Group will explore how collaboration can enable a standardized ecosystem for liquid-liquid drug delivery with an RTU 3 mL cartridge with internal by-pass and Magnitude 3.0 platforms. Thomas James, Customer Solutions Manager at SHL Medical, and Jake Skare, Product Manager EZ-fill® Cartridges at Stevanato Group, will discuss how industry collaboration enabled the development of a standardized container-device solution, helping de-risk development, streamline integration, and increase confidence in liquid-liquid drug delivery programs.

Learn how integrated container-device development can advance liquid-liquid combination therapies on October 29 at 5:45 PM.

27/10/2026

Three continents. Quite a few boarding passes. And a lot of good conversations along the way.

From Paris to Shanghai, Milan to Palm Springs, 2026 has taken our teams across some very different stages, booths, and meeting rooms. Along the way, we launched new devices, shared new research, celebrated a few wins, and met a lot of people doing interesting work across the industry.

Thank you to everyone who stopped by, joined a session, asked a question, shared an idea, or simply came over to say hello, and to all the teams behind the scenes who made each stop happen.

We’re not quite done with 2026 yet, but this felt like a good moment to look back 👇

26/10/2026

The real challenge in large-volume delivery is everything that has to work around the dose.

As volume increases, formulation, injection performance, usability, and commercial scale all start shaping the same device decision. Magnitude was designed around those trade-offs, with room to adapt as program needs evolve.

SHL Medical’s Sharon Liu explains what that looks like in practice.

24/10/2026

Breast cancer awareness starts with learning, listening, and looking out for one another. 🩷

Breast cancer remains the most common cancer among women worldwide, affecting millions of people and their families each year. This , SHL Medical colleagues across Switzerland, Sweden, the US, and Taiwan came together to highlight risk factors, prevention, and the importance of early detection.

Across our global sites, colleagues wore pink, gathered for pink fika, and joined physician-led sessions to deepen their understanding of breast cancer and early detection. These activities created space to show support for those affected and bring greater awareness into our workplaces and communities.

For SHL Medical, supporting better health extends beyond the devices we develop. It also means fostering a workplace where wellbeing is valued and colleagues can come together to support one another and care for the communities around us.

23/10/2026

Science becomes more meaningful when students can experience how it works in practice.

For the fifth consecutive year, SHL Medical is joining the NSTC Science Train to make science more accessible through hands-on learning. From October 19–24, the train will stop at 30 stations across 18 counties and cities, engaging students from more than 200 elementary and junior high schools through hands-on science activities.

Colleagues from SHL Medical, SHL Advantec, and SHL Technologies developed this year’s activities around industrial manufacturing, introducing principles behind injection molding, metal stamping, and autoinjector design.

We also trained students from Keelung, Chaochou, and Pingtung senior high schools to lead the activities with younger students, giving them an opportunity to pass on what they learned while gaining experience as activity leaders.

Through the Science Train, we’re proud to share our expertise beyond the workplace and create more opportunities for young people to engage with science. We remain committed to supporting education and building meaningful connections with local communities.

Learn more: https://bit.ly/4i3vG5R

22/10/2026

Historically, delivering two liquid drug products which cannot be coformulated into a single injection has required novel containers, novel devices, and often, novel user workflows.

Our recent compatibility work with BD suggests there may be a more streamlined path forward for combination therapy delivery. As part of the work presented in the ONdrugDelivery article, the BD® Dual-Injection Valve and BD Neopak™ 2.25 mL glass prefillable syringe were tested with our Molly 2.25 autoinjector.

The evaluation demonstrated compatibility of the dual-chamber system with our market-proven Molly autoinjector platform, assessing key attributes such as dose accuracy and injection time across various viscosity configurations.

Read the article to explore what this platform-compatible approach could mean for combination product development: https://bit.ly/4yolh9P

Adresse

Gubelstrasse 22
Zug
6300

Website

http://www.shl-medical.com/, https://www.shl-medical.com/trademarks

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn SHL Medical etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.